Abstract
Sequencing of parasite genomes opened the possibity to identify potential protein targets for drug development. Several protein targets have been found in the genome of Plasmodium falciparum, Trypanosoma cruzi, Trypanosoma brucei and Leishmania major. Bioinformatics analysis is an important tool for the identification of protein targets for drug development against parasitic diseases. In this review we comment about three protein targets, identified in parasite genomes, and discuss the main features that may guide future efforts for virtual screening initiatives.
Keywords: Virtual screening, parasites, molecular targets, drug design
Current Drug Targets
Title: Selection of Targets for Drug Development Against Protozoan Parasites
Volume: 10 Issue: 3
Author(s): Walter Filgueira de Azevedo Junior and Milena Botelho Pereira Soares
Affiliation:
Keywords: Virtual screening, parasites, molecular targets, drug design
Abstract: Sequencing of parasite genomes opened the possibity to identify potential protein targets for drug development. Several protein targets have been found in the genome of Plasmodium falciparum, Trypanosoma cruzi, Trypanosoma brucei and Leishmania major. Bioinformatics analysis is an important tool for the identification of protein targets for drug development against parasitic diseases. In this review we comment about three protein targets, identified in parasite genomes, and discuss the main features that may guide future efforts for virtual screening initiatives.
Export Options
About this article
Cite this article as:
de Azevedo Junior Filgueira Walter and Pereira Soares Botelho Milena, Selection of Targets for Drug Development Against Protozoan Parasites, Current Drug Targets 2009; 10 (3) . https://dx.doi.org/10.2174/138945009787581186
DOI https://dx.doi.org/10.2174/138945009787581186 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cannabinoids and Schizophrenia: Therapeutic Prospects
Current Pharmaceutical Design New Agents for the Treatment of Tuberculosis on Clinical Study Phases II/III
Current Respiratory Medicine Reviews Applications of Molecular Simulation in the Discovery of Antituberculosis Drugs: A Review
Protein & Peptide Letters QSAR Studies, Synthesis and Antibacterial Assessment of New Inhibitors Against Multidrug-Resistant Mycobacterium tuberculosis
Current Drug Discovery Technologies QSAR, Docking, and CoMFA Studies of GSK3 Inhibitors
Current Pharmaceutical Design Evaluation of In Vivo and In Vitro Antimicrobial Activities of a Selective Serotonin Reuptake Inhibitor Sertraline Hydrochloride
Anti-Infective Agents An Overview of Zinc Oxide Nanoparticles Produced by Plant Extracts for Anti-tuberculosis Treatments
Current Medicinal Chemistry Tuberculosis: Challenges to Improve the Treatment
Current Clinical Pharmacology Molecules and Metabolites from Natural Products as Inhibitors of Biofilm in Candida spp. pathogens
Current Topics in Medicinal Chemistry Predicting Drugs and Proteins in Parasite Infections with Topological Indices of Complex Networks: Theoretical Backgrounds, Applications and Legal Issues
Current Pharmaceutical Design Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds
Current Medicinal Chemistry Structure-based Discovery of Novel Antibacterials
Anti-Infective Agents in Medicinal Chemistry The Potential of Natural Diterpenes Against Tuberculosis: An Updated Review
Current Pharmaceutical Design Cationic Antimicrobial Peptides for Tuberculosis: A Mini-Review
Current Protein & Peptide Science QSAR and Docking Studies of HCV NS3 Serine Protease Inhibitors
Medicinal Chemistry 3D-QSAR Approaches in Drug Design: Perspectives to Generate Reliable CoMFA Models
Current Computer-Aided Drug Design Treatment Strategies of Obsessive-Compulsive Disorder and Panic Disorder/Agoraphobia
Current Topics in Medicinal Chemistry Computer Design of Vaccines: Approaches, Software Tools and Informational Resources
Current Computer-Aided Drug Design Immunology of O-Glycosylated Proteins: Approaches to the Design of a MUC1 Glycopeptide-Based Tumor Vaccine
Current Protein & Peptide Science Microwave-assisted Synthesis of Novel Triazolyl Pyrazolyl Pyrazoline Substituted Coumarins and Their Antimicrobial Activity
Current Microwave Chemistry